Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|March 13, 2003
New approaches to reversal of neuromuscular blockAnton Bom, John K Clark, Ronald PalinAnesthesia and Analgesia|December 21, 2006
The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodentsAlan J Byford, Alison Anderson, Philip S Jones, et al.Organic & Biomolecular Chemistry|May 13, 2005
Mutual induced fit in cyclodextrin-rocuronium complexesAlan Cooper, Margaret Nutley, Elizabeth J MacLean, et al.Bioorganic & Medicinal Chemistry|February 6, 2008
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic propertiesRonald Palin, John K Clark, Louise Evans, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockadeRonald Palin, John K Clark, Phill Cowley, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular blockJohn K Clark, Phill Cowley, Alan W Muir, et al.Bioorganic & Medicinal Chemistry|December 15, 2006
Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative propertiesRonald Palin, Anton Bom, John K Clark, et al.Journal of Medicinal Chemistry|April 19, 2002
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationshipsJulia M Adam, D Jonathan Bennett, Anton Bom, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Rapid access towards follow-up NOP receptor agonists using a knowledge based approachRonald Palin, John K Clark, Louise Evans, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonistsPhillip M Cowley, James Baker, David R Barn, et al.Pageof 2